NYSE - Delayed Quote USD

Globus Medical, Inc. (GMED)

50.37 -1.07 (-2.08%)
At close: 4:00 PM EDT
50.37 0.00 (0.00%)
After hours: 4:33 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,568,476.00
1,568,476.00
1,022,843.00
958,102.00
789,042.00
Cost of Revenue
548,174.00
548,174.00
263,725.00
239,223.00
217,463.00
Gross Profit
1,020,302.00
1,020,302.00
759,118.00
718,879.00
571,579.00
Operating Expense
818,452.00
818,452.00
522,867.00
524,021.00
456,107.00
Operating Income
201,850.00
201,850.00
236,251.00
194,858.00
115,472.00
Net Non Operating Interest Income Expense
20,130.00
20,130.00
14,233.00
9,297.00
13,952.00
Other Income Expense
-56,587.00
-56,587.00
-7,465.00
-23,748.00
-3,525.00
Pretax Income
165,393.00
165,393.00
243,019.00
180,407.00
125,899.00
Tax Provision
42,520.00
42,520.00
52,850.00
31,216.00
23,614.00
Net Income Common Stockholders
122,873.00
122,873.00
190,169.00
149,191.00
102,285.00
Diluted NI Available to Com Stockholders
122,873.00
122,873.00
190,169.00
149,191.00
102,285.00
Basic EPS
1.09
--
1.89
1.48
1.04
Diluted EPS
1.07
--
1.85
1.44
1.01
Basic Average Shares
113,087.00
--
100,469.00
100,734.00
98,580.00
Diluted Average Shares
114,630.00
--
102,643.00
103,623.00
100,971.00
Total Operating Income as Reported
133,142.00
133,142.00
227,951.00
171,953.00
111,433.00
Total Expenses
1,366,626.00
1,366,626.00
786,592.00
763,244.00
673,570.00
Net Income from Continuing & Discontinued Operation
122,873.00
122,873.00
190,169.00
149,191.00
102,285.00
Normalized Income
163,328.61
163,328.61
197,466.56
169,310.26
105,791.22
Net Interest Income
20,130.00
20,130.00
14,233.00
9,297.00
13,952.00
EBIT
201,850.00
201,850.00
236,251.00
194,858.00
115,472.00
EBITDA
346,583.00
346,583.00
304,503.00
264,725.00
178,346.00
Reconciled Cost of Revenue
454,473.00
454,473.00
213,208.00
187,882.00
171,420.00
Reconciled Depreciation
144,733.00
144,733.00
68,252.00
69,867.00
62,874.00
Net Income from Continuing Operation Net Minority Interest
122,873.00
122,873.00
190,169.00
149,191.00
102,285.00
Total Unusual Items Excluding Goodwill
-54,449.00
-54,449.00
-9,320.00
-24,328.00
-4,318.00
Total Unusual Items
-54,449.00
-54,449.00
-9,320.00
-24,328.00
-4,318.00
Normalized EBITDA
401,032.00
401,032.00
313,823.00
289,053.00
182,664.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-13,993.39
-13,993.39
-2,022.44
-4,208.74
-811.78
12/31/2020 - 8/3/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ATEC Alphatec Holdings, Inc.
12.24
-3.92%
 
OFIX Orthofix Medical Inc.
13.10
-3.39%
 
MASI Masimo Corporation
135.24
-0.50%
 
FNA Paragon 28, Inc.
8.97
-6.95%
 
ZBH Zimmer Biomet Holdings, Inc.
119.75
-1.17%
 
NARI Inari Medical, Inc.
38.07
-0.29%
 
IRTC iRhythm Technologies, Inc.
111.27
-4.43%
 
TMCI Treace Medical Concepts, Inc.
10.30
-3.47%
 
CNMD CONMED Corporation
61.90
-11.58%
 
NVCR NovoCure Limited
12.23
-0.89%